<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Immunology Product Guide &#187; pandemic swine flu</title>
	<atom:link href="http://www.immunologyproductguide.com/blog/tag/pandemic-swine-flu/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.immunologyproductguide.com/blog</link>
	<description>A comprehensive guide to immunology products for medical professionals</description>
	<lastBuildDate>Fri, 11 Jun 2010 10:09:04 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Roche Tamiflu Not Proven to Cut Flu Complications, Study Says</title>
		<link>http://www.immunologyproductguide.com/blog/2009/12/09/roche%e2%80%99s-tamiflu-not-proven-to-cut-flu-complications-study-says/</link>
		<comments>http://www.immunologyproductguide.com/blog/2009/12/09/roche%e2%80%99s-tamiflu-not-proven-to-cut-flu-complications-study-says/#comments</comments>
		<pubDate>Wed, 09 Dec 2009 13:31:00 +0000</pubDate>
		<dc:creator>Jim Marino</dc:creator>
				<category><![CDATA[influenza]]></category>
		<category><![CDATA[antiviral drug]]></category>
		<category><![CDATA[pandemic swine flu]]></category>
		<category><![CDATA[Roche Holding AG]]></category>
		<category><![CDATA[Tamiflu]]></category>
		<category><![CDATA[World Health Organization]]></category>

		<guid isPermaLink="false">http://www.immunologyproductguide.com/blog/?p=196</guid>
		<description><![CDATA[Roche Holding AG’s antiviral drug Tamiflu may not prevent complications from influenza in healthy adults, according to a review by an independent research group that reversed its previous findings that the medicine warded off pneumonia and other deadly conditions linked to the disease. The pill has been the mainstay of treatment for pandemic swine flu, [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.immunologyproductguide.com/blog/wp-content/uploads/2009/12/Roche.png"><img class="alignright size-full wp-image-197" style="margin: 5px" src="http://www.immunologyproductguide.com/blog/wp-content/uploads/2009/12/Roche.png" border="0" alt="Roche" width="200" height="95" /></a>Roche Holding AG’s antiviral drug Tamiflu may not prevent complications from influenza in healthy adults, according to a review by an independent research group that reversed its previous findings that the medicine warded off pneumonia and other deadly conditions linked to the disease. The pill has been the mainstay of treatment for pandemic swine flu, which has killed nearly 9,000 people since it emerged in April, according to the World Health Organization.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.immunologyproductguide.com/blog/2009/12/09/roche%e2%80%99s-tamiflu-not-proven-to-cut-flu-complications-study-says/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
